Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes MK Tripathi, K Doxtater, F Keramatnia, C Zacheaus, MM Yallapu, M Jaggi, ... Drug Discovery Today 23 (9), 1635-1643, 2018 | 97 | 2018 |
Phenyl‐Glutarimides: Alternative Cereblon Binders for the Design of PROTACs J Min, A Mayasundari, F Keramatnia, B Jonchere, SW Yang, J Jarusiewicz, ... Angewandte Chemie International Edition 60 (51), 26663-26670, 2021 | 63 | 2021 |
Identification of potent, selective, and orally bioavailable small-molecule GSPT1/2 degraders from a focused library of cereblon modulators G Nishiguchi, F Keramatnia, J Min, Y Chang, B Jonchere, S Das, M Actis, ... Journal of medicinal chemistry 64 (11), 7296-7311, 2021 | 61 | 2021 |
Thermodynamic solubility profile of carbamazepine–cinnamic acid cocrystal at different pH F Keramatnia, A Shayanfar, A Jouyban Journal of pharmaceutical sciences 104 (8), 2559-2565, 2015 | 52 | 2015 |
Ketoconazole ionic liquids with citric and tartaric acid: Synthesis, characterization and solubility study F Keramatnia, A Jouyban, H Valizadeh, A Delazar, A Shayanfar Fluid Phase Equilibria 425, 108-113, 2016 | 26 | 2016 |
Z probe, an efficient tool for characterizing long non-coding RNA in FFPE tissues MK Tripathi, C Zacheaus, K Doxtater, F Keramatnia, C Gao, MM Yallapu, ... Non-coding RNA 4 (3), 20, 2018 | 11 | 2018 |
The orally bioavailable GSPT1/2 degrader SJ6986 exhibits in vivo efficacy in acute lymphoblastic leukemia Y Chang, F Keramatnia, PS Ghate, G Nishiguchi, Q Gao, I Iacobucci, ... Blood 142 (7), 629-642, 2023 | 9 | 2023 |
Prediction of drug solubility data in polyethylene glycols+ water mixtures at various temperatures F Keramatnia, A Shayanfar, AH Bozorgi, M Mottaghi, A Jouyban Lat Am J Pharm 34, 1614-1621, 2015 | 7 | 2015 |
From PROTAC to inhibitor: Structure-guided discovery of potent and orally bioavailable BET inhibitors M Koravovic, A Mayasundari, G Tasic, F Keramatnia, TR Stachowski, ... European Journal of Medicinal Chemistry 251, 115246, 2023 | 1 | 2023 |
Substituted n-(2-(2, 6-dioxopiperidin-3-yl)-1, 3-dioxoisoindolin-5-yl) arylsulfonamide analogs as modulators of cereblon protein M Fisher, F Keramatnia, K McGowan, J Min, GA Nishiguchi, J Price, ... US Patent App. 18/368,497, 2024 | | 2024 |
Substituted n-(2-(2, 6-dioxopiperidin-3-yl)-1, 3-dioxoisoindolin-5-yl) arylsulfonamide analogs as modulators of cereblon protein M Fisher, F Keramatnia, K McGowan, J Min, GA Nishiguchi, J Price, ... US Patent App. 17/740,148, 2022 | | 2022 |
Targeting Protein Degradation to Uncover Novel Oncoprotein Drivers of Acute Leukemia F Keramatnia The University of Tennessee Health Science Center, 2022 | | 2022 |
Abstract LBA002: Targeting GSPT1 by a novel cereblon E3 ligase modulator for the treatment of Acute Lymphoblastic Leukemia F Keramatnia, Y Chang, G Nishiguchi, J Min, C Mullighan, M Fischer, ... Molecular Cancer Therapeutics 20 (12_Supplement), LBA002-LBA002, 2021 | | 2021 |
Sinteza i biološko profilisanje (+)-JQ1 amida kao BET inhibitora M Koravović, G Tasić, A Mayasundari, F Keramatnia, M Fischer, ... 57. Savetovanje Srpskog hemijskog društva. Kratki izvodi, Juni 18 i 19, 2021 …, 2021 | | 2021 |
Nove protein-ligand interakcije amidnih BET inhibitora otkrivene derivatizacijom (+)-JQ1 molekula M Koravović, G Tasić, A Mayasundari, F Keramatnia, T Stachowski, ... Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih …, 2021 | | 2021 |
Acknowledgement of Top Manuscript Reviewers (2019) A Shayanfar, S Hamedeyazdan, A Garjani, ABM Fadzelly, A Alizadeh, ... PHARMACEUTICAL SCIENCES 26 (1), 97-98, 2020 | | 2020 |
MUC13 interacts with SOX2 leading to cell stemness and Anoikis resistance in colorectal cancer K Doxtater, C Zacheaus, F Keramatnia, M Chaib, M Triparthi, S Chauhan Cancer Research 79 (13_Supplement), 2647-2647, 2019 | | 2019 |
Design and synthesis of Hsp90 PROTAC degraders as potential anticancer agents M Koravovića, G Tasića, A Mayasundarib, J Minb, F Keramatniab, ... Konkurs za izbor najboljih naučno-istraživačkih radova studenata doktorskih …, 2019 | | 2019 |
MUC13 is a novel molecular signature, for early detection and metastatic colorectal cancer MK Tripathi, C Zacheaus, K Doxtater, Z Stiles, F Keramatnia, N Zafar, ... Cancer Research 78 (13_Supplement), 5178-5178, 2018 | | 2018 |
Preparation and characterization of carbamazepine cocrystals with acidic coformers to improve their physicochemical properties F Keramatnia Tabriz University of Medical Sciences, Faculty of Pharmacy, 2015 | | 2015 |